AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33640068 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted IRS
Number of subjects: 0
Study 33640068 — intervention group
Group type: COMPARATOR
Intervention: Standard IRS
Number of subjects: 0
Study 32611831 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-lncRNA-based classifier for overall survival (OS)
Number of subjects: 0
Study 32611831 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-lncRNA-based classifier for recurrence
Number of subjects: 0
Study 32611831 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular-clinicopathological nomograms based on classifiers
Number of subjects: 0
Study 33421042 — intervention group
Group type: EXPERIMENTAL
Intervention: Clam Extract (CE) capsules, 3 times a day for 2 weeks
Number of subjects: 52
Study 33421042 — intervention group
Group type: COMPARATOR
Intervention: Control group received empty capsules identical in appearance to CE capsules
Number of subjects: 52
Study 34293124 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (4 g/day for 4 weeks in the form of DHA-rich fish oil)
Number of subjects: 0
Study 34293124 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA (4 g/day for 4 weeks in the form of ALA-rich flaxseed oil)
Number of subjects: 0
Study 32096243 — intervention group
Group type: EXPERIMENTAL
Intervention: Free gingival grafts (FGGs)
Number of subjects: 18
Study 32096243 — intervention group
Group type: COMPARATOR
Intervention: No-surgery (control)
Number of subjects: 18
Study 32096243 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed FGG group (8 implants from control group)
Number of subjects: 18
Study 33546912 — intervention group
Group type: EXPERIMENTAL
Intervention: High intrinsic motivation GPs
Number of subjects: 846
Study 33546912 — intervention group
Group type: EXPERIMENTAL
Intervention: Most intrinsically motivated GPs exposed to external regulation (accreditation)
Number of subjects: 846
Study 32334620 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure (12-min sessions, three times per week for four weeks on acupoints HT7, PC6, SP6)
Number of subjects: 0
Study 32334620 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 0
Study 35045327 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg once daily orally administered)
Number of subjects: 402
Study 35045327 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 402
Study 34137538 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of Carbimazole (OD-CMZ)
Number of subjects: 69
Study 34137538 — intervention group
Group type: COMPARATOR
Intervention: Divided dose of Carbimazole (DD-CMZ)
Number of subjects: 69
Study 32450080 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-visit IUD insertion
Number of subjects: 396
Study 32450080 — intervention group
Group type: EXPERIMENTAL
Intervention: Parity (associated with willingness to schedule a single-visit insertion)
Number of subjects: 396
Study 35094230 — intervention group
Group type: EXPERIMENTAL
Intervention: Building the micro‐stellated icosahedrons
Number of subjects: 27
Study 35094230 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 32417946 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic formula of Lactobacillus plantarum PBS067, Lactobacillus acidophilus PBS066 and Lactobacillus reuteri PBS072 with active prebiotics
Number of subjects: 60
Study 32417946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35594632 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal high-protein diet
Number of subjects: 2
Study 35594632 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 2
Study 33657109 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaysian preschoolers' VMI scores
Number of subjects: 435
Study 33657109 — intervention group
Group type: COMPARATOR
Intervention: Low-income families
Number of subjects: 435
Study 33657109 — intervention group
Group type: COMPARATOR
Intervention: Public preschools
Number of subjects: 435
Study 33657109 — intervention group
Group type: COMPARATOR
Intervention: Starting preschool at age six
Number of subjects: 435
Study 33657109 — intervention group
Group type: COMPARATOR
Intervention: Low maternal education level
Number of subjects: 435
Study 34353031 — intervention group
Group type: EXPERIMENTAL
Intervention: LHP's RRPF program (exercise group)
Number of subjects: 82
Study 34353031 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care (control group)
Number of subjects: 82
Study 32167382 — intervention group
Group type: EXPERIMENTAL
Intervention: YpsoPump® Orbit®micro (steel needle)
Number of subjects: 40
Study 32167382 — intervention group
Group type: EXPERIMENTAL
Intervention: YpsoPump® Orbit®soft (soft cannula)
Number of subjects: 40
Study 32167382 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 40
Study 35144650 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 165
Study 35144650 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 165
Study 33812168 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA (4 g daily)
Number of subjects: 40
Study 33812168 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA (in ApoE-/- mice)
Number of subjects: 40
Study 32076558 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple stenting
Number of subjects: 450
Study 32076558 — intervention group
Group type: COMPARATOR
Intervention: Complex stenting
Number of subjects: 450
Study 32076558 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer generation drug-eluting stents (simple stenting)
Number of subjects: 450
Study 32076558 — intervention group
Group type: COMPARATOR
Intervention: Newer generation drug-eluting stents (complex stenting)
Number of subjects: 450
Study 35604803 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (activating and interactive training sessions for nursing staff and consulting physicians)
Number of subjects: 227
Study 35604803 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 227
Study 36226089 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) combined with conventional treatment
Number of subjects: 0
Study 36226089 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 0
Study 33436470 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on astragalus for 48 weeks
Number of subjects: 118
Study 33436470 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 118
Study 33718001 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet- and App-based stress intervention (IG)
Number of subjects: 200
Study 33718001 — intervention group
Group type: COMPARATOR
Intervention: Internet-based psychoeducational program (CG)
Number of subjects: 200
Study 33218350 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole plus human menopausal gonadotropin (HMG) for endometrial preparation
Number of subjects: 120
Study 33218350 — intervention group
Group type: COMPARATOR
Intervention: Routine artificial hormonal endometrial preparation
Number of subjects: 120
Study 33080594 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Integrated Program (VIP) - 6-week intensive integrated lifestyle intervention
Number of subjects: 128
Study 33080594 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Integrated Program (VIP) - 12-month follow-up
Number of subjects: 128
Study 32801017 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral THC:CBD cannabis extract (2.5 mg THC and 2.5 mg CBD, 1-4 self-titrated capsules, three times daily from days -1 to 5)
Number of subjects: 81
Study 32801017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 32801017 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral THC:CBD cannabis extract
Number of subjects: 81
Study 34288040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate partner violence intervention education component
Number of subjects: 178
Study 34288040 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 178
Study 33161293 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training intervention consisting of Xbox 360 Kinect games performed for sixteen 30‐min sessions over 8 weeks
Number of subjects: 40
Study 33161293 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 40
Study 36122257 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided thoracic erector spinae plane block
Number of subjects: 60
Study 36122257 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided thoracic paravertebral block
Number of subjects: 60
Study 34056788 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive tendon-loading exercises (PTLE)
Number of subjects: 76
Study 34056788 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise therapy (EET)
Number of subjects: 76
Study 32805185 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg once daily
Number of subjects: 173
Study 32805185 — intervention group
Group type: COMPARATOR
Intervention: Voglibose 0.2 mg 3 times daily
Number of subjects: 173
Study 35380988 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga program
Number of subjects: 10
Study 35380988 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic and strength training (A+ST)
Number of subjects: 10
Study 33988886 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent procedure
Number of subjects: 146
Study 34500113 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent treatment (SBRT with immunotherapy)
Number of subjects: 37
Study 34500113 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment (SBRT followed by immunotherapy)
Number of subjects: 37
Study 34500113 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response
Number of subjects: 37
Study 34500113 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 37
Study 34500113 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 37
Study 32563642 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Atrial Late Gadolinium Enhancement (LA LGE)
Number of subjects: 68
Study 32563642 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of LA LGE to a multivariable risk prediction model
Number of subjects: 68
Study 32329037 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin administration (statin + group, 143 patients)
Number of subjects: 344
Study 32329037 — intervention group
Group type: COMPARATOR
Intervention: No statin administration (statin - group, 201 patients)
Number of subjects: 344
Study 32329037 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin administration (statin + group)
Number of subjects: 344
Study 32329037 — intervention group
Group type: COMPARATOR
Intervention: No statin administration (statin - group)
Number of subjects: 344
Study 32329037 — intervention group
Group type: EXPERIMENTAL
Intervention: Both statin (+) and statin (-) groups
Number of subjects: 344
Study 33611330 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% Sodium Carboxymethylcellulose (SCMC)
Number of subjects: 60
Study 33611330 — intervention group
Group type: COMPARATOR
Intervention: 0.4% Sodium Hyaluronate (SH)
Number of subjects: 60
Study 32034447 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-mg nicotine patch (NP)
Number of subjects: 127
Study 32034447 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch (PP)
Number of subjects: 127
Study 33861390 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago psyllium (10g/day for 7 weeks)
Number of subjects: 100
Study 33861390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34786629 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention for adolescent depression
Number of subjects: 12
Study 34454767 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-scale combination (0,1/2,3 or 0/1,2)
Number of subjects: 524
Study 34454767 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-scale inter-rater agreement
Number of subjects: 524
Study 32357088 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding for 2 months
Number of subjects: 349
Study 32357088 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers providing mostly or only breast milk at 2 months
Number of subjects: 349
Study 32357088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intended breastfeeding duration
Number of subjects: 349
Study 34256752 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined learning (animations and games)
Number of subjects: 82
Study 34256752 — intervention group
Group type: COMPARATOR
Intervention: Routine school education
Number of subjects: 82
Study 34773608 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Technosphere Insulin (TI) at doses of 10, 30, and 120 U
Number of subjects: 0
Study 34773608 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin lispro (LIS) at doses of 8, 30, and 90 U
Number of subjects: 0
Study 33966520 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture and telerehabilitation sessions (aerobic exercise and virtual reality training)
Number of subjects: 60
Study 33966520 — intervention group
Group type: COMPARATOR
Intervention: Telerehabilitation sessions (aerobic exercise and virtual reality training)
Number of subjects: 60
Study 35063451 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical intensivist consultation
Number of subjects: 71
Study 35063451 — intervention group
Group type: COMPARATOR
Intervention: Simulated observation by a critical care physician
Number of subjects: 71
Study 34112384 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary CT Angiography followed by Invasive Angiography
Number of subjects: 0
Study 34112384 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36018628 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated decision aid (n=693, 48.6%)
Number of subjects: 1425
Study 36018628 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=732, 51.4%)
Number of subjects: 1425
Study 32633158 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vancomycin (OV) at 50 mg/kg/day in 3 divided doses if weight <30kg, and 500 mg 3 times/day if weight ≥30kg.
Number of subjects: 59
Study 32633158 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vancomycin (OV) treatment.
Number of subjects: 59
Study 35471812 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg, amoxicillin 1000 mg, esomeprazole 40 mg, all twice daily for 14 days
Number of subjects: 579
Study 35471812 — intervention group
Group type: COMPARATOR
Intervention: Bismuth subcitrate 240 mg twice daily, amoxicillin 1000 mg three times daily, esomeprazole 40 mg twice daily for 14 days
Number of subjects: 579
Study 33504909 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (DMB)
Number of subjects: 50
Study 33504909 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (MMB)
Number of subjects: 50
Study 34006849 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenetic panel-based genotyping
Number of subjects: 77684
Study 34006849 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CYP2C19-CYP2D6 phenotypes
Number of subjects: 77684
Study 33280888 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted TMAO
Number of subjects: 0
Study 33280888 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted betaine
Number of subjects: 0
Study 33280888 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted carnitine
Number of subjects: 0
Study 33280888 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted choline
Number of subjects: 0
Study 33280888 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher risk of AD
Number of subjects: 0
Study 35007940 — intervention group
Group type: EXPERIMENTAL
Intervention: ICDs exposed to doses of 2, 5, or 10 Gy (6 MV) during radiation exposure
Number of subjects: 210
Study 35007940 — intervention group
Group type: EXPERIMENTAL
Intervention: PMs exposed to doses of 2, 5, or 10 Gy (6 MV) during radiation exposure
Number of subjects: 210
Study 35007940 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of PMs and ICDs after exposure
Number of subjects: 210
Study 35007940 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-MRI-compatible devices
Number of subjects: 210
Study 32040047 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed saline (37.5°C)
Number of subjects: 80
Study 32040047 — intervention group
Group type: COMPARATOR
Intervention: Nonwarmed saline (22°C‐24°C)
Number of subjects: 80
Study 35708557 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender oil through inhalation and foot massage
Number of subjects: 0
Study 35708557 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34018042 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ventral hernia repair (LVHR)
Number of subjects: 85
Study 34018042 — intervention group
Group type: COMPARATOR
Intervention: Open ventral hernia repair (OVHR)
Number of subjects: 85
Study 32209721 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg or 90 mg
Number of subjects: 747
Study 32209721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 747
Study 35985899 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based life-skills training program (22 weeks duration)
Number of subjects: 1473
Study 35985899 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 1473
Study 33607030 — intervention group
Group type: EXPERIMENTAL
Intervention: Social group intervention (sensitisation and education about MRDT)
Number of subjects: 18
Study 33607030 — intervention group
Group type: EXPERIMENTAL
Intervention: Social group plus provider intervention (social group intervention plus provider training in health communication about MRDT)
Number of subjects: 18
Study 33607030 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 18
Study 33607030 — intervention group
Group type: EXPERIMENTAL
Intervention: Social group plus provider intervention (social group intervention plus provider training about MRDT)
Number of subjects: 18
Study 32216468 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT5716 (Lc40) administered to mothers (n=139); 1 capsule/day containing 3×10^9 cfu Lc40
Number of subjects: 291
Study 32216468 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin) capsule administered to mothers (n=152); 1 capsule/day
Number of subjects: 291
Study 36397445 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest model
Number of subjects: 1905
Study 36397445 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 1905
Study 36397445 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality rate
Number of subjects: 1905
Study 32156479 — intervention group
Group type: EXPERIMENTAL
Intervention: RAAS blockers
Number of subjects: 110
Study 32156479 — intervention group
Group type: COMPARATOR
Intervention: Other antihypertensive drugs (Control)
Number of subjects: 110
Study 36314293 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric low carbohydrate diet
Number of subjects: 38
Study 36314293 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric moderate low fat diet
Number of subjects: 38
Study 36314293 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet without calorie restriction
Number of subjects: 38
Study 36314293 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 38
Study 33450113 — intervention group
Group type: EXPERIMENTAL
Intervention: Early neonatal deaths identified through retrospective chart review
Number of subjects: 2499
Study 33450113 — intervention group
Group type: EXPERIMENTAL
Intervention: Causes of early neonatal death
Number of subjects: 2499
Study 33450113 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidable factors identified
Number of subjects: 2499
Study 32957418 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment, 12 sessions over 4 weeks
Number of subjects: 144
Study 32957418 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA) treatment, 12 sessions over 4 weeks
Number of subjects: 144
Study 32957418 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group, 20 mg fluoxetine orally per day for 4 weeks
Number of subjects: 144
Study 32957418 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment
Number of subjects: 144
Study 32957418 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA) treatment
Number of subjects: 144
Study 32957418 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group
Number of subjects: 144
Study 36068716 — intervention group
Group type: EXPERIMENTAL
Intervention: Escherichia coli Nissle 1917 (EcN)
Number of subjects: 133
Study 36068716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 34120941 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports dance exercises
Number of subjects: 0
Study 34120941 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 32590885 — intervention group
Group type: EXPERIMENTAL
Intervention: Thicker custom-made mouthguard with 2-mm occlusal accommodation
Number of subjects: 25
Study 32590885 — intervention group
Group type: COMPARATOR
Intervention: Conventional mouthguard (Type A) with no occlusal accommodation
Number of subjects: 25
Study 33035738 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum PFAS levels (PFOA, PFOS, PFHxS, PFNA)
Number of subjects: 235
Study 32330638 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg misoprostol
Number of subjects: 129
Study 32330638 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg dinoprostone
Number of subjects: 129
Study 32330638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 36042401 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (LI) group
Number of subjects: 63
Study 36042401 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 63